TEMPO Selection, TAVR Coverage, AI Picks, and India’s Software Guidance
In this week’s Pathways Picks: FDA selects Dexcom as the first participant in the digital health TEMPO pilot; Industry and hospital groups call out CMS for tightening its proposed coverage policy language for transcatheter aortic valve replacements; UK issues AI regulation case studies; Health Canada complains of too much information; India finalizes its guidance on medical device software; and more global medtech policy updates.